The dual targeting potential of NGR was hypothesized to allow more consistent surface coverage relative to RGD, enhancing the ability to reach coagulation thresholds [72], and to allow targeting of larger tumor vessels which was shown to be limited when targeting αvβ3 alone [73]. The gene discussed is RTN4R; the disease is neoplasm.